These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 22813427)

  • 1. The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization.
    Hamley IW
    Chem Rev; 2012 Oct; 112(10):5147-92. PubMed ID: 22813427
    [No Abstract]   [Full Text] [Related]  

  • 2. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease and the amyloid β-protein.
    Walsh DM; Teplow DB
    Prog Mol Biol Transl Sci; 2012; 107():101-24. PubMed ID: 22482449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-β: the seeds of darkness.
    Fodero-Tavoletti MT; Villemagne VL; Rowe CC; Masters CL; Barnham KJ; Cappai R
    Int J Biochem Cell Biol; 2011 Sep; 43(9):1247-51. PubMed ID: 21601003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease.
    Matharu B; El-Agnaf O; Razvi A; Austen BM
    Peptides; 2010 Oct; 31(10):1866-72. PubMed ID: 20633587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of yeast to study the tau and amyloid-β abnormalities of Alzheimer's disease.
    Porzoor A; Macreadie IG
    J Alzheimers Dis; 2013; 35(2):217-25. PubMed ID: 23396350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemistry and molecular biology of amyloid beta-protein and the mechanism of Alzheimer's disease.
    Selkoe DJ
    Handb Clin Neurol; 2008; 89():245-60. PubMed ID: 18631749
    [No Abstract]   [Full Text] [Related]  

  • 8. Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity.
    Tõugu V; Tiiman A; Palumaa P
    Metallomics; 2011 Mar; 3(3):250-61. PubMed ID: 21359283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-n oligomers as therapeutic targets of Alzheimer's disease.
    Ono K; Yamada M
    J Neurochem; 2011 Apr; 117(1):19-28. PubMed ID: 21244429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
    Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
    Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron(II) binding to amyloid-β, the Alzheimer's peptide.
    Bousejra-ElGarah F; Bijani C; Coppel Y; Faller P; Hureau C
    Inorg Chem; 2011 Sep; 50(18):9024-30. PubMed ID: 21800824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A beta A4 amyloid precursor protein gene and Alzheimer's disease.
    Hendriks L; Van Broeckhoven C
    Eur J Biochem; 1996 Apr; 237(1):6-15. PubMed ID: 8620894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A commonly used Drosophila model of Alzheimer's disease generates an aberrant species of amyloid-β with an additional N-terminal glutamine residue.
    Allan K; Perez KA; Barnham KJ; Camakaris J; Burke R
    FEBS Lett; 2014 Oct; 588(20):3739-43. PubMed ID: 25171862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Compensatory function of transthyretin in Alzheimer's disease].
    Shwartsman AL; Sarantseva SV
    Tsitologiia; 2011; 53(10):772-7. PubMed ID: 22232933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of steric zipper on the aggregation of the MVGGVV peptide derived from the amyloid beta peptide.
    Chang LK; Zhao JH; Liu HL; Wu JW; Chuang CK; Liu KT; Chen JT; Tsai WB; Ho Y
    J Biomol Struct Dyn; 2010 Aug; 28(1):39-50. PubMed ID: 20476794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid beta/A4 peptide associated with Alzheimer's disease and cerebral amyloid angiopathy.
    Hirai S; Okamoto K
    Intern Med; 1993 Dec; 32(12):923-5. PubMed ID: 8204971
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomization of amyloid-β-peptide(1-42) conformation by sulfonated and sulfated nanoparticles reduces aggregation and cytotoxicity.
    Saraiva AM; Cardoso I; Saraiva MJ; Tauer K; Pereira MC; Coelho MA; Möhwald H; Brezesinski G
    Macromol Biosci; 2010 Oct; 10(10):1152-63. PubMed ID: 20480510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?
    Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC
    Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc-induced dimerization of the amyloid-β metal-binding domain 1-16 is mediated by residues 11-14.
    Kozin SA; Mezentsev YV; Kulikova AA; Indeykina MI; Golovin AV; Ivanov AS; Tsvetkov PO; Makarov AA
    Mol Biosyst; 2011 Apr; 7(4):1053-5. PubMed ID: 21350790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the Cu+ binding in the 1-16 region of the amyloid-β peptide involved in Alzheimer's disease.
    Furlan S; Hureau C; Faller P; La Penna G
    J Phys Chem B; 2010 Nov; 114(46):15119-33. PubMed ID: 21038888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.